Clinical trial
Assessment of Metabolic Profiles of Lower Extremity Arterial Disease in Patiens Withe Type 2 Diabetes Via LC-MS-based Nontargeted Metabolomic Approach
NCT05068895 is registered in ClinicalTrials.gov with Zhiming Zhu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Metabolic Profiles of Lower Extremity Arterial Disease in Patiens Withe Type 2 Diabetes Via LC-MS-based Nontargeted Metabolomic Approach
- Lead sponsor
- Zhiming Zhu
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2021
- Completion date
- October 15, 2021
- Enrollment
- 74 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.